Aurora Cannabis Inc. has signed a deal to buy Whistler Medical Marijuana Corp. in an all-stock deal worth up to $175 million, including certain milestone payments.
Edmonton-based Aurora says the acquisition of the privately held company is expected to provide it with a suite of premium and organic certified products.
Whistler operates two indoor licensed production facilities, include one in Whistler, B.C., and another a short drive from the resort town.
READ MORE: Aurora Cannabis to acquire Mexican company following partnership deal
Once the second location reaches full capacity, the facilities are expected to have a combined production capacity of over 5,000 kilograms per year.
The deal is subject to customary closing conditions, as well as third party and regulatory approvals.
Shares in Aurora closed at $8.47 on the Toronto Stock Exchange on Friday.
READ MORE: Aurora Cannabis ramping up production but recreational pot shortages will likely linger
Comments